Open AccessCatalyzing momentum in male contraceptive development
Author(s) -
Logan M. Nickels,
Kevin Shane,
Heather L. Vahdat
Publication year - 2021
Publication title -
biology of reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.366
H-Index - 180
eISSN - 1529-7268
pISSN - 0006-3363
DOI - 10.1093/biolre/ioab208
Subject(s) - commercialization , unintended pregnancy , male contraceptive , new product development , agency (philosophy) , economic growth , family planning , reproductive technology , public relations , population , biology , business , political science , marketing , pregnancy , research methodology , economics , sociology , medicine , environmental health , social science , lactation , genetics
Globally, nearly half of all pregnancies are unplanned. Male contraceptives offer the potential to decrease unintended pregnancy and introduce contraceptive equity, but decades of research have yet to bring a novel product to market. New funding avenues from the philanthropic sector seek to stimulate research in male contraceptives through investments, grants, and support for trainees alongside other programs that encourage product development and ultimately commercialization. This Forum outlines the purpose of and funding opportunities provided by Male Contraceptive Initiative, a funding agency and non-profit focused on the advancement of non-hormonal, reversible contraceptive technologies for those who produce sperm.